The payers' perspective on gene therapies

Nat Biotechnol. 2015 Sep;33(9):902-4. doi: 10.1038/nbt.3332.

Authors

Nicolas Touchot¹, Mathias Flume²

Affiliations

¹ groupH, Strategy Consulting, London, UK.
² Kassenärztliche Vereinigung Westfalen Lippe, Prescription Management, Dortmund, Germany.

PMID: 26348952
DOI: 10.1038/nbt.3332

No abstract available

Publication types

Comment

MeSH terms

Genetic Therapy / economics*
Humans